Dr Jinwei Zhang is a Principal Investigator in Medicine at the University of Exeter Medical School, UK. Professor, Director of Research Center of Chemical Kinomics, State key Laboratory of Bioorganic Chemistry and Natural products, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, China. Visiting Professor at Xiamen University China, Visiting fellow at the Yale School of Medicine. His laboratory studies ion channels, transporters, and signaling pathways that associated with human diseases, for examples, stroke that regulated by WNK-SPAK/OSR1-KCC2/NKCC1, hypertension that regulated by WNK-SPAK/OSR1-NCC, and concern with elucidating and targeting ion transporters, kinases, protein-protein interactions using genetic mouse models, small molecules, CRISPR/Cas9 gene-editing technologies, and electrophysiology to aid discovery and validation of new potential drug targets. He is internationally recognized for his expertise in cellular chloride homeostasis and cell volume regulation and drug discovery. He has published more than 80 articles in journals including Cell, Nature Medicine, Cell Metabolism, Neuron, Nature Communications, EMBO molecular medicine, Science Signaling, Human Molecular Genetics etc. and has achieved more than 3250 citations, H-index=30, i10-index=49. His current research is supported by the NIH R01, The Royal Society UK, NSFC, Alzheimer's Research UK and Commonwealth Commission Funding etc. He is an Associate Editor for the Frontiers in Pharmacology, Frontiers in Microbiology, and Frontiers in Physiology, Editor in Chief for the Journal of Modern Biology and Drug Discovery. He is currently a member of the editorial boards of 40 scientific journals and completed editing >70 manuscripts and completed editing >70 manuscripts, as well as a reviewer for more than 60 scientific journals and completed reviewing >100 manuscripts.